Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Anna, Brona"'
Autor:
Justyna Kuliczkowska-Płaksej, Aleksandra Jawiarczyk-Przybyłowska, Aleksandra Zdrojowy-Wełna, Anna Brona, Marek Bolanowski
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e2840bb510c05453d0ea04c782aab92
https://doi.org/10.1530/endoabs.90.ep313
https://doi.org/10.1530/endoabs.90.ep313
Autor:
Eliza Kubicka, Marek Bolanowski, Anna Bohdanowicz-Pawlak, Aleksandra Jawiarczyk-Przybyłowska, Anna Brona, Joanna Syrycka
Publikováno v:
Polish archives of internal medicine. 131(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44b263d714d4712cdd50d371a5852a67
https://pubmed.ncbi.nlm.nih.gov/33624953
https://pubmed.ncbi.nlm.nih.gov/33624953
Publikováno v:
ISGE Series ISBN: 9783030636494
It has been shown that environmental factors play a role in the development of obesity and insulin resistance in PCOS women. There is a bulk of evidence that endocrine-disrupting chemicals, advanced glycated end products, and vitamin D deficiency con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b3e75dd6d99bf736db2fa2c1e5c422a
https://doi.org/10.1007/978-3-030-63650-0_4
https://doi.org/10.1007/978-3-030-63650-0_4
Publikováno v:
Journal of Addiction Medicine. 12:184-192
Millions of men use androgenic-anabolic steroids (AAS) to stimulate muscle growth and improve physical appearance. Although 1 out of 3 people who uses androgenic-anabolic steroids develops a steroid use disorder, the effects of the drugs on the centr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6800b59e52138d6d3c72e87f15e932dc
https://doi.org/10.1097/adm.0000000000000395
https://doi.org/10.1097/adm.0000000000000395
Publikováno v:
Polish Archives of Internal Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d502807fed116a9c104fa45a463d4958
https://doi.org/10.20452/pamw.14922
https://doi.org/10.20452/pamw.14922
Publikováno v:
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 35(12)
We present an unusual case of Turner syndrome (TS) and Cushing disease (CD) in a young woman, admitted to our department seven years after a successful surgical removal of ACTH-secreting pituitary tumor. To our knowledge, this is the first ever repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::436f42df2e7d2c032d6cd6b15b3f2810
https://pubmed.ncbi.nlm.nih.gov/31242778
https://pubmed.ncbi.nlm.nih.gov/31242778
Publikováno v:
Pre-Menopause, Menopause and Beyond ISBN: 9783319635392
The appearance of menopause is combined with the incidence of many diseases typical of middle age, i.e., thyroid disorders, osteoporosis, and cardiovascular diseases. Thyroid disorders, especially subclinical hypothyroidism and subclinical hyperthyro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e82173d3bd69e781a07bb41d88381baa
https://doi.org/10.1007/978-3-319-63540-8_8
https://doi.org/10.1007/978-3-319-63540-8_8
Publikováno v:
Pre-Menopause, Menopause and Beyond ISBN: 9783319635392
Metformin (MET) is the most widely used oral antidiabetic agent, currently recommended as first-line therapy not only for all newly diagnosed type 2 diabetes mellitus (DM2) patients but also for prediabetic syndromes associated with insulin resistanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab168e16cd70a95f12d7e1c26f811332
https://doi.org/10.1007/978-3-319-63540-8_11
https://doi.org/10.1007/978-3-319-63540-8_11
Autor:
Andrzej Milewicz, Łukasz Łaczmański, Anna Bohdanowicz-Pawlak, Justyna Kuliczkowska-Płaksej, Anna Brona, Urszula Dorobisz, Agnieszka Lenarcik-Kabza
Publikováno v:
Endokrynologia Polska. 65:416-421
Introduction: The aim was to assess associations among PCOS and NAFLD, the lipoprotein lipase polymorphism gene, and metabolic disorders in PCOS. Material and methods: In 184 women with PCOS and 125 healthy, premenopausal volunteers, sex steroids, li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d1aed32004bfd8e6343076209995ee3
https://doi.org/10.5603/ep.2014.0058
https://doi.org/10.5603/ep.2014.0058
Autor:
Justyna Kuliczkowska-Płaksej, Anna Brona, Łukasz Łaczmański, Agnieszka Lenarcik-Kabza, Katarzyna Kolackov, Maurycy Pawlak, Anna Trzmiel-Bira, Andrzej Milewicz, Bozena Bidzińska-Speichert
Publikováno v:
Endokrynologia Polska. 65:181-188
Introduction: Polycystic ovary syndrome (PCOS) is associated with an increasing number of metabolic comorbidities. About 50% of PCOS patients are obese, and insulin resistance affects up to 70% of these women. The endocannabinoid system contributes t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0e6ba6f6c86400c251ee5e84ed63389
https://doi.org/10.5603/ep.2014.0025
https://doi.org/10.5603/ep.2014.0025